Clinical trial
Comprehensive Screening for Women at High Genetic Risk for Developing Breast…
NCT00255060 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00255060 |
|---|---|
| Title | Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer |
| Official title | Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Institutes of Health (NIH) NIH United States Department of Defense U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 100 |
| Start date | Nov 1, 2001 |
| Primary completion | Jul 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Nov 17, 2005 |
| Last update posted | Jul 20, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: